Michael A. DesJardin - 02 Mar 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP, Technical Operations
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Mar 2022
Net transactions value: -$3,401,752
Form type: 4
Filing time: 04 Mar 2022, 15:19:19 UTC
Previous filing: 24 Jan 2022
Next filing: 14 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Sale	$2,084,828	-21,482	-16%	$97.05	116,078	02 Mar 2022	Direct	F1
transaction	HZNP	Ordinary Shares	Sale	$1,316,924	-13,518	-12%	$97.42	102,560	02 Mar 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $97.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $97.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $97.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $97.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.